James Howard-Tripp
Directeur Général chez STAGEZERO LIFE SCIENCES LTD.
Fortune : 6 052 $ au 30/04/2024
Postes actifs de James Howard-Tripp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Président | 19/07/2013 | - |
| Directeur Général | 10/08/2016 | - | |
| Public Communications Contact | 01/01/2002 | - | |
| Directeur/Membre du Conseil | 01/01/2002 | 19/07/2013 | |
| Independent Dir/Board Member | 01/01/2002 | 19/07/2013 | |
| Canadian Healthcare Licensing Association | Corporate Officer/Principal | 20/08/2009 | - |
| Président | - | 20/08/2009 | |
Innovative Diagnostic Laboratory LLP
 Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Directeur Général | - | - |
GeneNews (USA), Inc.
 GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Directeur/Membre du Conseil | - | - |
| President | - | - |
Historique de carrière de James Howard-Tripp
Anciens postes connus de James Howard-Tripp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 22/12/2010 | 14/03/2011 |
| Directeur Général | 01/01/1999 | 14/03/2011 | |
| President | 01/01/1999 | 14/03/2011 | |
| Allelix Biopharmaceuticals, Inc. | Directeur des opérations | 01/01/1996 | - |
| Wyeth Ayerst Canada, Inc. | Corporate Officer/Principal | - | - |
| Allelix Neuroscience, Inc. | President | - | - |
| Paladin Labs Europe Ltd. | President | - | - |
Statistiques
Internationale
| Canada | 6 |
| Etats-Unis | 4 |
| Irlande | 2 |
Opérationnelle
| President | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
Sectorielle
| Health Technology | 5 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
| Paladin Labs Europe Ltd. | |
| Canadian Healthcare Licensing Association | |
| Allelix Neuroscience, Inc. | |
| Wyeth Ayerst Canada, Inc. | |
Innovative Diagnostic Laboratory LLP
Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Health Services |
GeneNews (USA), Inc.
GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Health Technology |
- Bourse
- Insiders
- James Howard-Tripp
- Expérience
